Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Houssiau, F. Houssiau, J. Devogelaer, J. Damme, C. Deuxchaisnes, J. Snick (1988)
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.Arthritis and rheumatism, 31 6
L. Aarden, E. Groot, O. Schaap, P. Lansdorp (1987)
Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 17
J. Ohara, W. Paul (1985)
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 315
LA Aarden, ER De Groot, OL Shaap, PM Lansdorp (1987)
Production of hybridoma growth factor by monocytes, 17
(1989)
Bijvoet 0
J Heath, J Saklatvala, MC Meikle, SJ Atkinson, JJ Reynolds (1985)
Pig interleukin‐1 (catabolin) is a potent stimulator of bone resorption, 37
(1985)
The Phytiologic, Metabolic and Immunologic Actions of Interleukin-I
P. Stashenko, F. Dewhirst, M. Rooney, L. Desjardins, J. Heeley (1987)
Interleukin-1 beta is a potent inhibitor of bone formation in vitro.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2 6
(1985)
Stud - ies on the control o f IL - 1 - stimulated bone resorption
J O'Hara, WE Paul (1985)
Production of a monoclonal antibody to and characerisation of a B cell stimulatory factor 1, 315
J. Gauldie, C. Richards, D. Harnish, P. Lansdorp, H. Baumann (1987)
Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences of the United States of America, 84 20
M. Gowen, D. Wood, R. Russell (1985)
Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.The Journal of clinical investigation, 75 4
J Van Damme, JV Van Beeuman, B Decock, J Van Snick, M De Ley, A Billiau (1988)
Separation and comparison of two monokines with lymphocyte‐activating factor activity: IL‐1 beta and hybridoma growth factor (HGF), 140
JP Brakenhoff, E. Groot, RF Evers, H. Pannekoek, L. Aarden (1987)
Molecular cloning and expression of hybridoma growth factor in Escherichia coli.Journal of immunology, 139 12
(1987)
patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum
M. Ogawa, Clark Sc (1988)
Synergistic interaction between interleukin-6 and interleukin-3 in support of stem cell proliferation in culture.Blood cells, 14 2-3
J. Damme, J. Beeumen, B. Decock, J. Snick, M. Ley, A. Billiau (1988)
Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.Journal of immunology, 140 5
U. Lerner (1987)
Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorptionJournal of Bone and Mineral Research, 2
B. Boyce, T. Aufdemorte, I. Garrett, A. Yates, G. Mundy (1989)
Effects of interleukin-1 on bone turnover in normal mice.Endocrinology, 125 3
J. Damme, G. Opdenakker, R. Simpson, M. Rubira, S. Cayphas, A. Vink, A. Billiau, J. Snick (1987)
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factorThe Journal of Experimental Medicine, 165
T. Mosmann (1983)
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.Journal of immunological methods, 65 1-2
M. Gowen, G. Nedwin, G. Mundy (1986)
Preferential inhibition of cytokine‐stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1
(1989)
Interleukin-6: Its production by osteoblasts and activity to induce bone resorption
J. Feyen, F. Padova, U. Trechsel, P. Elford (1989)
Interleukin‐6 is produced by bone and modulated by parathyroid hormoneJournal of Bone and Mineral Research, 4
C. Löwik, G. Pluijm, H. Bloys, K. Hoekman, O. Bijvoet, L. Aarden, S. Papapoulos (1989)
Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.Biochemical and biophysical research communications, 162 3
M. Gowen, G. Mundy (1986)
Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro.Journal of immunology, 136 7
P. Stashenko, F. Dewhirst, Monique Rooney, Laurie Desjardins, J. Heeley (1987)
Interleukin‐1β is a potent inhibitor of bone formation in vitroJournal of Bone and Mineral Research, 2
M. Kawano, T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, Hideo Tanaka, A. Kuramoto, T. Kishimoto (1988)
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 332
T. Hirano, K. Yasukawa, H. Harada, T. Taga, Yasuo Watanabe, T. Matsuda, S. Kashiwamura, K. Nakajima, K. Koyama, A. Iwamatsu, S. Tsunasawa, F. Sakiyama, H. Matsui, Y. Takahara, T. Taniguchi, T. Kishimoto (1986)
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 324
Recombinant human interleukin‐6 (IL‐6) was assessed for its ability to stimulate bone resorption in prelabeled mouse calvariae in vitro. IL‐6 had no effect on bone resorption at concentrations ranging from 300 to 10,000 U/ml (3–1000 pg/ml). Neither the presence of indomethacin nor prolonged incubation periods (96 h) affected this result. IL‐6 did not affect resorption stimulated by human recombinant IL‐1α (rIL‐1α) but inhibited resorption stimulated by parathyroid hormone (PTH) and 1,25‐dihydroxyvitamin D3 [1,25‐(OH)2D3]. rIL‐1α, PTH, and 1,25‐(OH)2D3 induced IL‐6 release by calvariae. We conclude from these studies that IL‐6 does not stimulate bone resorption in neonatal mouse calvariae. However, it may act as a locally produced inhibitor and therefore a paracrine regulator of bone resorption induced by osteotropic hormones. IL‐6 could also function as a long‐range stimulator of systemic reactions and acute‐phase responses to local inflammatory and neoplastic lesions in bone.
Journal of Bone and Mineral Research – Oxford University Press
Published: Jan 1, 1991
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.